Last October, when Nova-Tech President Gloria Thesenvitz celebrated her company’s grand opening in a new $10.5 million facility in Grand Island, she said she believed it to be the only all-new aseptic fill facility in the United States dedicated to custom manufacturing of injectables, large-volume animal health products.
The company started in Grand Island in 1988 with a staff of six people and began operations mostly as an animal blood collection and sterile serum facility. In the late 1990s, the company started investigating the possibility of manufacturing injectables for the animal health industry. There was a market shortage for these over-the-counter products, and the facility had available manufacturing capacity so the new product line seemed a natural fit for the company.
It turned out to be a smart move for Nova-Tech, one that led to renewed growth for the company. Today, the company is focused on the aseptic fill of large volume and small volume sterile injectables, specifically fluids, minerals and vitamin products custom manufactured for animal health distributors.
There are approximately 50 employees working at the new 50,000-square-foot site at 4705 Gold Core Road in the Platte Valley Industrial Park, located on Grand Island’s southern end. The company has also purchased an adjoining lot for future expansion.
Nova-Tech’s products include lactated ringers, sterile saline, CMPK, 50 percent dextrose, calcium 23 percent and additional aqueous-based products such as vitamins and injectable minerals. All products carry private labels and are distributed by large animal health companies.
Thesenvitz said she has witnessed the educational and economic benefits that can be realized for communities when science-based businesses are developed. Bio Nebraska’s role in ensuring the health of these businesses is important. “The opportunity to join forces, to network, to better our communities and our businesses benefits us all,” said Thesenvitz.
National Bioeconomy Blueprint
2016 Bioscience Industry